Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T19:51:15.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.16.8) and a new date (2025-07-20), replacing the previous revision (v2.16.6) and date (2025-06-19).
    Difference
    1%
    Check dated 2025-07-26T16:23:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-19T12:33:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-12T11:23:53.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    4%
    Check dated 2025-07-05T09:17:45.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-21T00:43:22.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.